Opportunity
SAM #75N98027Q00038SB_PCA-NIA-11810
NIH request for Baxter/Hill-Rom Helux Pro surgical lighting and wireless fiber photometry equipment
Buyer
NIH Office of Logistics and Acquisition Operations
Posted
November 16, 2026
Respond By
December 08, 2026
Identifier
75N98027Q00038SB_PCA-NIA-11810
NAICS
339112, 423450
The NIH is seeking surgical lighting and wireless fiber photometry equipment for clinical and neuroscience research operations. - Government buyer: National Institutes of Health (NIH), National Institute on Aging (NIA), Intramural Research Program / Clinical Research Unit; Office of the Director, Office of Acquisitions. - OEMs and named suppliers: Baxter/Hill-Rom for the Helux Pro surgical light; Doric is named as the software the photometry systems must support. No reseller is identified. - Surgical lighting — quantity 1: Baxter/Hill-Rom Helux Pro system for the NIA procedure suite, replacing an unsupported ceiling-mounted system. Includes HP100 lighthead, MS-1 mounting kit, single-arm installation, integrated 4K camera and Helion video equipment, 55-inch 4K DICOM display with wall mount, cabling and 4K60 video routing, installation, and legacy-light removal. Key part numbers include HP100, MS-1, INS-L1, SRV-PROPLUS-HPRO, 4K100, VR401111-1, VR401112, CP401206-B, AC500920K, FS-E2101DT, AC500814, RXNM552, CKSTD001, MHDMI50, AC500967, INS-ORI-003, DEINS-L, INS-PM, and 1385367. - Notable requirements: Medical-grade LED illumination, CRI95 and deep-red rendering, ceiling-mounted single-arm suspension, dual-channel recording, DICOM display, 4K60 routing, and turnkey installation. - Wireless fiber photometry equipment for NIH/NIDA rodent research: 2 base stations; 4 wireless photometry headstages with 2.5 mm ferrules, one integrated photodetector, two integrated LEDs, and 40mAh Battery A; 1 battery charger; 2 non-functional 2.5 mm-ferrule headstages; 10 mono fiberoptic cannulae; 1 mid-performance workstation; and 1 Neuroscience Console. Part numbers are not provided. Systems must be compatible with Doric software. - Services and coverage: Surgical-light installation and facility integration (INS-L1), inside delivery and trash removal (TRASH-REMOVAL; INSIDE-DELIVERY), Helion installation (INS-ORI-003), light de-installation (DEINS-L), project management (INS-PM), three-year Helux Pro Protection+ coverage (SRV-PROPLUS-HPRO), and four-year Helion Protection+ coverage (1385367). Photometry equipment includes a one-year repairs, parts, and labor warranty. - Delivery/performance: Photometry systems are requested within 10 weeks of award. Surgical-light delivery is requested as soon as possible; no defined performance period is stated.
Description
The National Institute on Aging (NIA), Intramural Research Program (IRP), operates the Clinical Research Unit (CRU) located at the MedStar Harbor Hospital campus in Baltimore, Maryland.
The CRU serves as the primary dedicated clinical facility supporting human longitudinal and translational aging research protocols, including the Baltimore Longitudinal Study of Aging (BLSA), the Genetic and Epigenetic Signatures of Translational Aging Laboratory Testing (GESTALT) study, and specialized clinical trials investigating age-related functional decline and metabolic disorders.
A cornerstone of these intramural clinical protocols involves invasive outpatient biopsy procedures—specifically percutaneous skeletal muscle biopsies, subcutaneous adipose tissue biopsies, and dermal skin punch biopsies. These procedures provide vital biospecimens for cellular, molecular, and physiological characterization of human aging.
The existing ceiling-mounted surgical lighting system currently deployed in the CRU procedure suite has reached the end of its useful service life (End-of-Life / EOL). The legacy unit is experiencing persistent operational failures. Critical replacement parts are no longer manufactured or supported by the original equipment manufacturer (OEM), rendering the existing unit non-serviceable. Because medical-grade illumination is a non-negotiable safety and operational prerequisite for procedural asepsis, precise anatomical depth perception, tissue differentiation, and hemostasis, the current state presents an unacceptable clinical risk and threatens immediate disruption to approved NIA protocol timelines.